• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AppliedVR Lands $29M for VR Platform to Treat Chronic Pain

Share:

March 31, 2021

What You Should Know:

– AppliedVR, a Los Angeles, CA-based company advancing the next generation of digital medicine, today announced $29 million in Series A funding, bringing its total funds raised to date to $35 million. The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures, and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year.

– Founded in 2015, AppliedVR provides virtual reality-based treatments aimed at comprehensively treating chronic pain. Combining well-established cognitive-behavioral therapies with mindfulness exercises, the company’s EaseVRx solution recently became the first virtual reality (VR) prescription therapeutic to receive Breakthrough Device Designation from the FDA for treatment-resistant fibromyalgia and chronic intractable lower back pain.

– AppliedVR’s technology is already trusted by more than 200 of the top healthcare provider organizations in the world, including Geisinger and Cleveland Clinic, who are advancing separate NIDA-funding clinical trials to study VR as an opioid-sparing tool for acute and chronic pain. The company also has partnered with the University of California at San Francisco (UCSF) to study how digital therapeutic platforms, including virtual and augmented reality, can be used to improve care access for underserved populations. AppliedVR also is engaged with multiple payers, testing VR as a cost-effective solution for treating chronic pain.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– The company also just released results from its pivotal eight-week randomized clinical trial, finding that the EaseVRx device produced “clinically meaningful” improvement in multiple pain outcomes, and had high participant satisfaction and engagement.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Bruker Announces Acquisition of Scientific Software Provider ArxspanBruker Announces Acquisition of Scientific Software Provider Arxspan
  • The Top 5 Pharma M&A Deals of 2020The Top 5 Pharma M&A Deals of 2020
  • Steward Health Care System to Deploy Meditech Expanse EHR Across 35 HospitalsSteward Health Care System to Deploy Meditech Expanse EHR Across 35 Hospitals
  • NVIDIA Partners with AstraZeneca and the University of Florida for AI-Powered Drug DiscoveryNVIDIA Partners with AstraZeneca and the University of Florida for AI-Powered Drug Discovery
  • Luma Health’s $16M Series B will Help it Pursue Larger Health System ClientsLuma Health’s $16M Series B will Help it Pursue Larger Health System Clients
  • Proscia and Ibex Medical Analytics Partner to Improve Prostate Cancer Diagnosis with AI-Powered WorkflowsProscia and Ibex Medical Analytics Partner to Improve Prostate Cancer Diagnosis with AI-Powered Workflows
  • Mentice to Acquire Eqip and MyIRlog™Mentice to Acquire Eqip and MyIRlog™
  • Professional Soccer Players Score Telehealth Partner for Mental HealthProfessional Soccer Players Score Telehealth Partner for Mental Health

Trending This Week

  • Denials Management Named Most Time-Consuming Task in RCM
  • Why Adopting Value-Based Care Models for Autism Care Is Imperative
  • Why AI-Driven Cancer Screening Will Soon Become Standard of Care
  • Bioventus Completes Divestiture of its Wound Business
  • Enzo Biochem Reports Significant Progress Toward Completing the Clinical Lab Asset Sale
  • eMolecules Acquires Specs Compound Handling B.V.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications